Plasma Fatty Acid Composition Is Associated with Histological Findings of Nonalcoholic Steatohepatitis

Plasma Fatty Acid Composition Is Associated with Histological Findings of Nonalcoholic Steatohepatitis

The relationship between advanced nonalcoholic steatohepatitis (NASH) and plasma fatty acid composition remains unknown. We aimed to examine the plasma fatty acid composition in biopsy-confirmed nonalcoholic fatty liver disease (NAFLD) and evaluate the relationship between histological findings and...

Full description

Bibliographic Details
Main Authors:	Teruki Miyake, Shinya Furukawa, Bunzo Matsuura, Osamu Yoshida, Masumi Miyazaki, Akihito Shiomi, Sayaka Kanzaki, Hironobu Nakaguchi, Kotaro Sunago, Yoshiko Nakamura, Yusuke Imai, Takao Watanabe, Yasunori Yamamoto, Yohei Koizumi, Yoshio Tokumoto, Masashi Hirooka, Teru Kumagi, Masanori Abe, Yoichi Hiasa
Format:	Article
Language:	English
Published:	MDPI AG 2022-10-01
Series:	Biomedicines
Subjects:	plasma fatty acids fatty liver disease histology fibrosis nonalcoholic steatohepatitis
Online Access:	https://www.mdpi.com/2227-9059/10/10/2540

Similar Items

Combined evaluation of Fibrosis‐4 index and fatty liver for stratifying the risk for diabetes mellitus
by: Yasuhiko Todo, et al.
Published: (2022-09-01)

Fatty liver with metabolic disorder, such as metabolic dysfunction‐associated fatty liver disease, indicates high risk for developing diabetes mellitus
by: Teruki Miyake, et al.
Published: (2022-07-01)

Role of B Cell-Activating Factor in Fibrosis Progression in a Murine Model of Non-Alcoholic Steatohepatitis
by: Kozue Kanemitsu-Okada, et al.
Published: (2023-01-01)

Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis
by: Kuei-Chuan Lee, et al.
Published: (2023-01-01)

Differential Lipidomics, Metabolomics and Immunological Analysis of Alcoholic and Non-Alcoholic Steatohepatitis in Mice
by: Erika Dorochow, et al.
Published: (2023-06-01)

Dietary fatty acids and risk of non-alcoholic steatohepatitis: A national study in the United States
by: Xiao-Ting Lu, et al.
Published: (2022-07-01)

MAFLD Criteria May Overlook a Subtype of Patient with Steatohepatitis and Significant Fibrosis
by: Huang J, et al.
Published: (2021-07-01)

Serum Fibroblast Growth Factor 21 Is Markedly Decreased following Exercise Training in Patients with Biopsy-Proven Nonalcoholic Steatohepatitis
by: Jonathan G. Stine, et al.
Published: (2023-03-01)

Radiofrequency Ablation Covering the Entire Tumor Blood Drainage Area Improves Survival in Hepatocellular Carcinoma
by: Masashi Hirooka, et al.
Published: (2021-07-01)

Increased Expression of RUNX1 in Liver Correlates with NASH Activity Score in Patients with Non-Alcoholic Steatohepatitis (NASH)
by: Savneet Kaur, et al.
Published: (2019-10-01)

The Role of Noninvasive <sup>13</sup>C-Octanoate Breath Test in Assessing the Diagnosis of Nonalcoholic Steatohepatitis
by: Carmen Fierbinteanu-Braticevici, et al.
Published: (2022-11-01)

Plasma Lipids Profile in the Prediction of Non-Alcoholic Steatohepatitis in Adults: A Case-Control Study
by: Georgios Kalopitas, et al.
Published: (2023-08-01)

Dietary Long-Chain Fatty Acids Accelerate Metabolic Dysfunction in Guinea Pigs with Non-Alcoholic Steatohepatitis
by: Kamilla Pedersen, et al.
Published: (2023-05-01)

Liver Biopsy Hydroxyproline Content Is a Diagnostic for Hepatocellular Carcinoma in Murine Models of Nonalcoholic Steatohepatitis
by: Tyler L. Bissoondial, et al.
Published: (2020-10-01)

Modulating sphingosine 1-phosphate receptor signaling skews intrahepatic leukocytes and attenuates murine nonalcoholic steatohepatitis
by: Chieh-Yu Liao, et al.
Published: (2023-04-01)

A Simple Index for Nonalcoholic Steatohepatitis—HUFA—Based on Routinely Performed Blood Tests
by: Milica Culafic, et al.
Published: (2019-06-01)

Overexpression of Interleukin-8 Promotes the Progression of Fatty Liver to Nonalcoholic Steatohepatitis in Mice
by: Ye Eun Cho, et al.
Published: (2023-10-01)

Assessment of Classification Models and Relevant Features on Nonalcoholic Steatohepatitis Using Random Forest
by: Rafael García-Carretero, et al.
Published: (2021-06-01)

Recurrent and de novo non-alcoholic steatohepatitis following orthotopic liver transplantation
by: Raquel F. Liermann GARCIA, et al.
Published: (2001-10-01)

The burden of nonalcoholic steatohepatitis (NASH) in the United States
by: Elliot B. Tapper, et al.
Published: (2023-04-01)

The Medium-Chain Fatty Acid Receptor GPR84 Mediates Myeloid Cell Infiltration Promoting Steatohepatitis and Fibrosis
by: Tobias Puengel, et al.
Published: (2020-04-01)

Downregulation of ANP32B exerts anti-apoptotic effects in hepatocellular carcinoma.
by: Yoshinori Ohno, et al.
Published: (2017-01-01)

Differential methylation patterns in lean and obese non-alcoholic steatohepatitis-associated hepatocellular carcinoma
by: Emma Hymel, et al.
Published: (2022-12-01)

Does hepatocellular carcinoma in non-alcoholic steatohepatitis exist in cirrhotic and non-cirrhotic patients?
by: A.L. Chagas, et al.
Published: (2009-10-01)

Fatty acid metabolism and its regulation/
by: Shosaku, Numa
Published: (1984)

Cholesterol Exacerbates the Pathophysiology of Non-Alcoholic Steatohepatitis by Upregulating Hypoxia-Inducible Factor 1 and Modulating Microcirculatory Dysfunction
by: Evelyn Nunes Goulart da Silva Pereira, et al.
Published: (2023-12-01)

Predictors of patient survival following liver transplant in non-alcoholic steatohepatitis: A systematic review and meta-analysis
by: Adam Minich, et al.
Published: (2022-08-01)

Targeting MRG15 for the treatment of nonalcoholic steatohepatitis
by: Yao Zhang, et al.
Published: (2022-12-01)

Metabolic dysfunction-associated fatty liver disease and metabolic-associated steatohepatitis: a review of pathogenesis and potential pharmacological targets
by: Samaneh Olapour, et al.
Published: (2022-01-01)

Non-Alcoholic Steatohepatitis (NASH) and Organokines: What Is Now and What Will Be in the Future
by: João Paulo Margiotti dos Santos, et al.
Published: (2022-01-01)

Fortifying Butterfat with Soybean Oil Attenuates the Onset of Diet-Induced Non-Alcoholic Steatohepatitis and Glucose Intolerance
by: Victor Sánchez, et al.
Published: (2021-03-01)

Use of Ultrasound Microscopy for Ex Vivo Analysis of Acoustic Impedance in Mouse Liver with Steatohepatitis
by: Hideki Kumagai, et al.
Published: (2020-12-01)

Semaglutide in the treatment of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
by: Magdalena Mazurek, et al.
Published: (2023-02-01)

Specific Gut Microbial Environment in Lard Diet-Induced Prostate Cancer Development and Progression
by: Hiromi Sato, et al.
Published: (2022-02-01)

Process for the production of fatty alcohols by catalytic hydrogenation of fatty acids and their derivatives /
by: 394609 Eisenlohr, Karl-Heinz, et al.

Production of fatty alcohols from fatty acids /
by: 394629 Voeste, Theodor, et al.

The chemistry of dibasic and polybasic fatty acids /
by: 290781 Johnson, R. W.

The Neutrophil-to-Lymphocyte Ratio as A Noninvasive Marker in Patients with Biopsy-Proven Non-Alcoholic Steatohepatitis
by: Mehmet Asıl, et al.
Published: (2016-12-01)

Imbalance of mitochondrial fusion in peripheral blood mononuclear cells is associated with liver fibrosis in patients with metabolic dysfunction-associated steatohepatitis
by: Thanaput Kunlayawutipong, et al.
Published: (2024-03-01)

Gut Microbiota Induced by Pterostilbene and Resveratrol in High-Fat-High-Fructose Fed Rats: Putative Role in Steatohepatitis Onset
by: Iñaki Milton-Laskibar, et al.
Published: (2021-05-01)